Inventor
GUOQING CAO
Inventor
CN
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides28%
C07BGeneral methods of organic chemistry3%
C07DHeterocyclic compounds3%
C12NMicroorganisms or enzymes3%
PatentTitleYear
12,479,922Humanized monoclonal antibody targeting BCMA and having human monkey cross-reactivity202512,435,144Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers202512,384,786Cyclic molecules as Bruton's tyrosine kinase inhibitor202511,866,500Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers202411,780,923PD-L1 antibody, antigen-binding fragment thereof and medical application thereof202311,525,005Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof202211,471,503Use of KOR agonist in combination with MOR agonist in preparing drug for treating pain202211,365,255PD-1 antibody, antigen-binding fragment thereof, and medical application thereof202211,208,484Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to JIANGSU HENGRUI MEDICINE CO (7)· patent assignee history
2021–2025Patents assigned to SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD (5)· patent assignee history
2021–2025Based in CN· patent location history
2022–2025Patents assigned to Shanghai hengrui pharmaceutical co ltd (5)· patent assignee history
2025Patents assigned to CYTOLYNX THERAPEUTICS HONG KONG LTD (1)· patent assignee history
2025Patents assigned to MINGHUI PHARMACEUTICAL HANGZHOU LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JIANGSU HENGRUI MEDICINE CO | 7 | 2021–2025 |
| SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD | 5 | 2021–2025 |
| Shanghai hengrui pharmaceutical co ltd | 5 | 2022–2025 |
| CYTOLYNX THERAPEUTICS HONG KONG LTD | 1 | 2025 |
| MINGHUI PHARMACEUTICAL HANGZHOU LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 9 | 2021–2025 |